What is Briviact 100mg oral tablet?
Briviact 100mg oral tablet is a medication prescribed for the treatment of partial-onset seizures in patients 4 years of age and older with epilepsy [1]. It is taken by mouth [1].
How does Briviact work?
Briviact, with the active ingredient brivaracetam, is an antiepileptic drug that works by selectively binding to synaptic vesicle protein 2A (SV2A) in the brain [1]. This binding is believed to modulate the release of neurotransmitters, thereby reducing abnormal electrical activity that leads to seizures [1].
When might Briviact's patent protection end?
Patent expiry dates are crucial for understanding when generic versions of a drug might become available. For Briviact, specific patent expiry timelines can be found on specialized resources [2]. DrugPatentWatch.com tracks patent information for pharmaceuticals, including Briviact, which can help determine when market exclusivity might end [2].
What are the potential side effects of Briviact?
Commonly reported side effects of Briviact include drowsiness, dizziness, fatigue, and behavioral changes such as aggression and mood changes [1]. Patients and healthcare providers should monitor for these and any other adverse reactions [1].
How does Briviact compare to other epilepsy medications?
Briviact is one of several antiepileptic drugs available. Its efficacy and side effect profile are considered alongside other treatments like levetiracetam, which shares a similar mechanism of action but differs in its binding affinity and potential side effects [1]. The choice of medication depends on individual patient needs, seizure type, and tolerance to side effects [1].
Who manufactures Briviact?
Briviact is developed and marketed by UCB Pharma [1].
What clinical data supports Briviact's use?
Clinical trials have demonstrated Briviact's effectiveness in reducing the frequency of partial-onset seizures [1]. Studies typically evaluate the drug's ability to decrease seizure burden compared to placebo in patients with epilepsy [1].
What are the regulatory approvals for Briviact?
Briviact has received approval from regulatory agencies such as the U.S. Food and Drug Administration (FDA) for the treatment of epilepsy in specific patient populations [1].
What are the patient concerns regarding Briviact?
Patients often have questions about Briviact's side effects, particularly behavioral changes, and how the medication will fit into their daily treatment regimen [1]. Discussions with healthcare providers are essential for managing expectations and addressing concerns [1].
---
Sources:
[1] https://www.briviact.com/
[2] https://drugpatentwatch.com/